GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹137 Cr | ₹122 Cr | ₹19 Cr | ₹23 Cr | ₹17 Cr |
What is the latest Net Current Assets ratio of GENNEX LABORATORIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹137 Cr |
| Mar2024 | ₹122 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹23 Cr |
| Mar2021 | ₹17 Cr |
How is Net Current Assets of GENNEX LABORATORIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹137 Cr | 12.40 | |
| Mar2024 | ₹122 Cr | 533.85 | |
| Mar2023 | ₹19 Cr | -16.56 | |
| Mar2022 | ₹23 Cr | 32.37 | |
| Mar2021 | ₹17 Cr | - | |
Compare Net Current Assets of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹246.8 Cr | -3.7% | -8.3% | -16.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -3.7% |
-8.3% |
-16.9% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses